Keywords: novartis, seeks, european, starlix, ok, filed, approval

Novartis seeks US, European Starlix OK

Article | 23 December 1999

Print This

Novartis has filed for US and European approval of Starlix (nateglinide)for type 2 diabetes, a novel drug which is chemically ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in